In phase II trials for dermal applications, TB-500 has shown promising results in patients with pressure ulcers, stasis ulcers, and epidermolysis bullosa [7]
However, for specific, stubborn injuries or in advanced research protocols, some investigators do opt for a localized approach
Van Gaal, M.D., Ph.D., Ildiko Lingvay, M.D., M.P.H., M.S.C.S., Barbara M
The B12 Injection is the perfect pick-me-up for older adults
The scale is different, but the math works the same way
The mechanism of this combined effect appears to be sequential: TB-500 mobilizes and migrates repair cells to the injury site (via actin regulation and chemotactic signaling), while BPC-157 creates the optimal local microenvironment (via angiogenesis, growth factor expression, and NO modulation) for those cells to perform effective repair once they arrive